Bavarian Nordic A/S (OMX: BAVA) announced today that the UK Medicines and Healthcare products Regulatory Agency (MHRA) h…
Timegrip announced the acquisition of Germany-based Software4You, a provider of HR controlling and personnel cost planni…
Audited results confirm full-year revenue of DKK 5,716 million and EBITDA of DKK 1,603 million. Two new early-stage…
First chikungunya vaccine approved for persons as young as 12 years old, addressing an unmet need for chikungunya preven…
Tech transfer of MVA-BN® will help increase global mpox vaccine manufacturing capacity and further expand the equitable…
Bavarian Nordic A/S (OMX: BAVA) today announced its intent to launch a share buy-back program of up to DKK 150 million i…
Bavarian Nordic A/S (OMX: BAVA) will announce its 2024 third quarter results on Friday, November 15, 2024. The manageme…
Bavarian Nordic A/S (OMX: BAVA) announced today the initiation of a clinical study of the MVA-BN® mpox/smallpox vaccine…
On 7th October 2024, the Notified Body TÜV SÜD Danmark ApS (NB 2443) has issued its first certificate in accordance with…
Whether authentic safaris, expedition cruises or exclusive sports events, the Albatros Travel Group is an extremely vers…
